Who has been buying Aprogen stock?

0 distinct insiders have filed 0 disclosed insider purchases in Aprogen (007460), most recently on 2026-05-01. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.

How many insider filings does Aprogen have?

Aprogen has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-01-10 to 2026-05-01.

Do insider buys in Korean stocks predict returns?

Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Aprogen 007460

Company

에이프로젠Aprogen

Insiders

Buys

Total Value

—

Avg Return

—

Last Filing

2026-05-01

Aprogen (007460) has 0 disclosed insider purchases and 0 disclosed disposals on record, filed by 0 distinct insiders. The earliest filing StockDrifts holds for Aprogen is dated 2025-01-10; the most recent is 2026-05-01.

Price & insider activity (12 months)

Recent insider trades

Date	Type	Source	Insider	Position	Shares	Price at filing	Return	Value
2026-05-01	BUY	신규선임	김정출 Kim Jeong-chul	president	74.9K	₩293	+1582.6%	₩22M ($15K)
2026-04-20	BUY	제3자배정유상증자	지베이스 Gbase	-	468.9K	₩293	+0.0%	₩137M ($95K)
2026-04-16	SELL	주식병합	배소현 Sohyun Bae	Managing Director	-98.4K	₩293	-1582.6%	₩29M ($20K)
2026-04-16	SELL	주식병합	염영숙 Youngsook Yeom	Managing Director	-94.7K	₩293	-1582.6%	₩28M ($19K)
2026-04-16	SELL	주식병합	진석민 Seokmin Jin	Managing Director	-119.6K	₩293	-1582.6%	₩35M ($24K)
2026-04-16	SELL	주식병합	채은희 Chae Eun-hee	Managing Director	-49.8K	₩293	-1582.6%	₩15M ($10K)
2026-04-16	SELL	주식병합	김용태 Yongtae Kim	Managing Director	-7.2K	₩293	-1582.6%	₩2M ($1K)
2026-04-16	SELL	주식병합	지베이스 Gbase	-	-67.0M	₩293	+0.0%	₩19.6B ($13.6M)
2026-04-16	SELL	주식병합	강선주 Seonju Kang	executive	-185.0K	₩293	+0.0%	₩54M ($38K)
2026-04-16	SELL	주식병합	김재섭 Jaeseop Kim	executive	-12.4M	₩293	+0.0%	₩3.6B ($2.5M)
2026-04-16	SELL	주식병합	넥스코닉스 Nexconics	-	-24.7M	₩293	+0.0%	₩7.2B ($5.0M)
2025-01-10	BUY	신규선임	김용태 Yongtae Kim	Assistant Managing Director	7.7K	₩796	-47.2%	₩6M ($4K)

Frequently asked questions

Who has been buying Aprogen stock?: 0 distinct insiders have filed 0 disclosed insider purchases in Aprogen (007460), most recently on 2026-05-01. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Aprogen have?: Aprogen has 0 buy-side and 0 sell-side disclosures on record, spanning 2025-01-10 to 2026-05-01.
Do insider buys in Korean stocks predict returns?: Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean regulatory filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

More on this data

Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.